
The most common (> 20%) adverse reactions, including laboratory abnormalities, with Larotrectinib were increased AST, increased ALT, anemia musculoskeletal pain, fatigue, hypoalbuminemia, neutropenia, increased alkaline phosphatase, cough, leukopenia, constipation, diarrhea, dizziness, hypocalcemia, nausea, vomiting, pyrexia, lymphopenia, and abdominal pain.
from FDA,2022.11
Common and Serious Adverse Reactions of LarotrectinibLike other medicines, larotrectinib may cause adverse reactions.Very common adverse reactions (affecting more than 1 in 10 peop···【more】
Article source:Lucius LaosRelease date:2026-04-09Recommended:44
Neurological and Hepatic Adverse Reactions to Watch for with LarotrectinibDuring treatment with VITRAKVI, you need to pay special attention to two categories of potentially serious···【more】
Article source:Lucius LaosRelease date:2026-04-09Recommended:38
Serious Side Effects That May Occur with LarotrectinibLarotrectinib may cause several serious side effects that require close attention from patients and caregivers. First, central···【more】
Article source:Lucius LaosRelease date:2026-04-08Recommended:42
The tropomyosin receptor kinase (TRK) fusion protein produced by the fusion of the neurotrophic tyrosine receptor kinase (NTRK) gene is a major oncogenic driver that is rare in a v···【more】
Article source:Lucius LaosRelease date:2024-11-19Recommended:323

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: